Table 3 Clinical Data of the Patients who received a long course of radiotherapy
From: Microvessel density as new prognostic marker after radiotherapy in rectal cancer
Survived (n = 17) | Deceased (n = 11) | p | |
|---|---|---|---|
Age M ± SE, years | 67.5 ± 1.9 | 67.8 ± 2.9 | 0.64 |
MVD M ± SE, microvessel/mm2 | 117.6 ± 5.8 | 161.2 ± 11.6 | 0.001 |
Sex, % | |||
Male | 35.3 | 18.2 | 0.3 |
Female | 64.7 | 81.8 | |
Tumor, % | |||
pT1/T2 | 41.2 | 27.3 | 0.45 |
pT3/T4 | 58.8 | 72.7 | |
Lymph node metastases (pN), % | |||
Absent | 88.2 | 54.5 | 0.044 |
Present | 11.8 | 45.5 | |
Histological grade (pG), % | |||
Very well/well | 64.7 | 54.5 | 0.59 |
Moderate/poor | 35.3 | 45.5 |